
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Journal
- Events
- Suppliers
- Home
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Events
- Suppliers
The new company will manage ongoing sales and enable better service to its accounts. The company, located in the US, shall be managed by Mr. Elzaphan Hotam, previously Enzymotec's VP of business development.
03/04/08 Enzymotec has announced the opening of a subsidiary in the US. The new company will manage ongoing sales and enable better service to its accounts.
The company, located in the US, shall be managed by Mr. Elzaphan Hotam, previously Enzymotec's VP of business development.
"This is a significant move for Enzymotec", says Mr. Hotam. "Beyond better service and faster response. we believe it would also enable us to expand our services to other markets as-well as to serve as a local base for additional business activities", concludes Mr. Hotam.
Enzymotec is an Israeli biotech company, that develops and produces novel ,lipid-based health ingredients for dietary supplements and functional foods. The company's leading products are:, SharpPS and SharpPS GOLD for cognitive performance improvement of seniors , CardiaBeat offering a broad health effect to reduce CVD risks and InFat for balanced nutrition in infant formula.
Upcoming webinars

The new math of functional eating in the GLP-1 era: addressing texture, nutrients, and health
Jungbunzlauer

The No-Compromise Formula: Ensuring Superior Taste in Nutrition-Focused Formulations
Biospringer by Lesaffre

Oat-Standing Ingredients - Showcasing Irish Grain Through Innovation
Tirlán Ingredients







